Action | Date | Index | Provider |
---|---|---|---|
Join | 2017 | Pharma, Biotech & Life Science | Saudi Exchange Co |
Leave | 2017 | Industrial Investment | Saudi Exchange Co |
Join | 1993 | Industrial Investment | Saudi Exchange Co |
Join | 1993 | Tadawul All Share Index (TASI) | Saudi Exchange Co |
Saudi Pharmaceutical Industries and Medical Appliances Corp |
Prince Salman Bin Muhammed Bin Saud street - AS SAHAFAH P.O.Box 20001 Riyadh 11455, Kingdom of Saudi Arabia |
T : +966 11 2523320 |
F : +966 11 2523300 |
www.spimaco.com.sa |
investor.relations@spimaco.sa |
Title | Name | As Of |
---|---|---|
Chairman: | Mohammed Al Nahas | 2021 |
CEO: | Khaled Al Khattaf | 2021 |
Deputy Chairman: | Ammar Al Khudairy | 2019 |
Board Member: | Khalid Al Gwaiz | 2019 |
Abdulrahman Al Thinyan | 2022 | |
Faisal Shaker | 2019 | |
Fahad Al Rabiah | 2022 | |
Mai AlAjaji | 2022 | |
Mohammad Mohammad | ||
Adill Ahmed |
Date | Title | File |
---|---|---|
2023 | SPIMACO Quarterly Financials Report Q2 2023 | |
2023 | SPIMACO announces SAR 79 million net income in 1H 2023 and raises FY 2023 guidance | |
2023 | SPIMACO Quarterly Financials Report Q1 2023 | |
2023 | SPIMACO Announces 85% year-on-year net income growth to SAR 57 million in 1Q 2023 | |
2023 | SPIMACO Annual Financials Report 2022 | |
2023 | SPIMACO Announces FY 2022 Financial Results | |
2023 | SPIMACO Announces a Revamped Patient-Centric Strategy to Build the National Champion in the Saudi Pharma Industry | |
2022 | SPIMACO completes strategic review and rolls out revamped 5-year strategy | |
2022 | SPIMACO Quarterly Financials Report Q3 2022 | |
2022 | SPIMACO Quarterly Financials Report Q2 2022 | |
2022 | SPIMACO Quarterly Financials Report Q1 2022 |